Aptevo Therapeutics Inc. — Director's Dealing 2018

Jun 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2018-06-01

Reporting Person: Grant Grady III (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-01	Stock Option (right to buy)	$5.49	A	25000	Acquired	2028-05-31	Common Stock (25000)	Direct

Footnotes

F1: The option vests in three equal annual installments beginning on May 31, 2019.